Synergy Biomedical received FDA 510(k) clearance and commenced full launch of BIOSPHERE® MIS PUTTY, comprising a pre-loaded bone graft cannula and trigger-based delivery system for open, mini-open and percutaneous minimally invasive procedures.
The system is available as a kit (with dispenser and putty-filled cannula) and in individual replacement cannulas to reload the delivery system.
BIOSPHERE bioactive glass-based bone graft putty has been marketed in the U.S. since 2013 and received CE Mark approval in 2017.
Synergy Biomedical received FDA 510(k) clearance and commenced full launch of BIOSPHERE® MIS PUTTY, comprising a pre-loaded bone graft cannula and trigger-based delivery system for open, mini-open and percutaneous minimally invasive procedures.
The system is available as a kit (with dispenser and putty-filled cannula) and in individual...
Synergy Biomedical received FDA 510(k) clearance and commenced full launch of BIOSPHERE® MIS PUTTY, comprising a pre-loaded bone graft cannula and trigger-based delivery system for open, mini-open and percutaneous minimally invasive procedures.
The system is available as a kit (with dispenser and putty-filled cannula) and in individual replacement cannulas to reload the delivery system.
BIOSPHERE bioactive glass-based bone graft putty has been marketed in the U.S. since 2013 and received CE Mark approval in 2017.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more
Copy to clipboard 
